Medication Utilization at School Age for Children Born Preterm

Jo Ann D'Agostino; Molly Passarella; Ashley E Martin; Scott A Lorch

doi:10.1016/j.jpeds.2019.11.015

Medication Utilization at School Age for Children Born Preterm

J Pediatr. 2020 Apr:219:250-253.e2. doi: 10.1016/j.jpeds.2019.11.015. Epub 2020 Jan 3.

Authors

Jo Ann D'Agostino¹, Molly Passarella², Ashley E Martin², Scott A Lorch³

Affiliations

¹ Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA; Center for Perinatal and Pediatric Health Disparities Research, The Children's Hospital of Philadelphia, Philadelphia, PA.
² Center for Perinatal and Pediatric Health Disparities Research, The Children's Hospital of Philadelphia, Philadelphia, PA.
³ Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA; Center for Perinatal and Pediatric Health Disparities Research, The Children's Hospital of Philadelphia, Philadelphia, PA; The University of Pennsylvania School of Medicine, Philadelphia, PA; Senior Scholar, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA. Electronic address: lorch@email.chop.edu.

PMID: 31910993
DOI: 10.1016/j.jpeds.2019.11.015

Abstract

We explored medication use by children born preterm at 5-8 years of age. Compared with children born at full term, children born preterm had higher medication use that included most therapeutic classifications. Although asthma and chronic lung disease influenced use, prematurity remained an independent risk factor.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Child
Child, Preschool
Cohort Studies
Drug Therapy / statistics & numerical data*
Female
Humans
Infant, Newborn
Infant, Premature
Male
Retrospective Studies
Risk Factors

Grants and funding

R01 HD057168/HD/NICHD NIH HHS/United States